Association between IRF-5 polymorphisms and risk of acute coronary syndrome

DNA and Cell Biology

Volumn 29, Issue 1, 2010, Pages 19-23

  Fan, Jing Han ^a   Gao, Lin Bo ^a   Pan, Xin Min ^a   Li, Cui ^a   Liang, Wei Bo ^a   Liu, Jin ^a   Li, Yi ^a   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 5;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE GENE; INDEL MUTATION; INTERFERON REGULATORY FACTOR 5 GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; INTERFERON REGULATORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 74049161888     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0929     Document Type: Article

References (22)

1. Anderson, K.M., Wilson, P.W., Odell, P.M., and Kannel, W.B. (1991). An updated coronary risk profile. A statement for health professionals. Circulation 83, 356-362.
2. Antonicelli, R., Olivieri, F., Bonafè, M., Cavallone, L., Spazzafumo, L., Marchegiani, F., Cardelli, M., Recanatini, A., Testarmata, P., Boemi, M., Parati, G., and Franceschi, C. (2005). The interleukin-6-174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 103, 266-271.
3. Barnes, B.J., Field, A.E., and Pitha-Rowe, P.M. (2003). Virusinduced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J Biol Chem 278, 16630-16641.
4. Barnes, B.J., Kellum, M.J., Field, A.E., and Pitha, P.M. (2002). Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 22, 5721-5740.
5. Barnes, B.J., Richards, J., Mancl, M., Hanash, S., Beretta, L., and Pitha, P.M. (2004). Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279, 45194-45207.
6. Barro, M., and Patton, J.T. (2007). Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF-5, and IRF7. J Virol 81, 4473-4481.
7. Dideberg, V., Kristjansdottir, G., Milani, L., Libioulle, C., Sigurdsson, S., Louis, E., Wiman, A.C., Vermeire, S., Rutgeerts, P., Belaiche, J., Franchimont, D., Van Gossum, A., Bours, V., and Syvänen, A.C. (2007). An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF-5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 16, 3008-3016.
8. Gao, L.B., Zhou, B., Zhang, L., Wei, Y.S., Wang, Y.Y., Liang, W.B., Lv, M.L., Pan, X.M., Chen, Y.C., and Rao, L. (2008). R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome. BMC Med Genet 9, 74.
9. Graham, R.R., Kyogoku, C., Sigurdsson, S., Vlasova, I.A., Davies, L.R., Baechler, E.C., Plenge, R.M., Koeuth, T., Ortmann, W.A., Hom, G., Bauer, J.W., Gillett, C., Burtt, N., Cunninghame Graham, D.S., Onofrio, R., Petri, M., Gunnarsson, I., Svenungsson, E., Rönnblom, L., Nordmark, G., Gregersen, P.K., Moser, K., Gaffney, P.M., Criswell, L.A., Vyse, T.J., Syvänen, A.C., Bohjanen, P.R., Daly, M.J., Behrens, T.W., and Altshuler, D. (2007). Three functional variants of IFN regulatory factor 5 (IRF-5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 104, 6758-6763.
10. Hansson, G.K. (2005). Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352, 1685-1695.
11. Heinemeyer, T., Wingender, E., Reuter, I., Hermjakob, H., Kel, A.E., Kel, O.V., Ignatieva, E.V., Ananko, E.A., Podkolodnaya, O.A., Kolpakov, F.A., Podkolodny, N.L., and Kolchanov, N.A. (1998). Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26, 362-367.
12. Hu, G., Mancl, M.E., and Barnes, B.J. (2005). Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res 65, 7403-7412.
13. Kannel, W.B. (1985). Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 110, 1100-1107.
14. Lee, Y.H., and Nath, S.K. (2005). Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 118, 434-443.
15. Mälarstig, A., Sigurdsson, S., Eriksson, P., Paulsson-Berne, G., Hedin, U., Wallentin, L., Siegbahn, A., Hamsten, A., and Syvänen, A.C. (2008). Variants of the interferon regulatory factor 5 gene regulate expression of IRF-5mRNA in atherosclerotic tissue but are not associated with myocardial infarction. Arterioscler Thromb Vasc Biol 28, 975-982.
16. Mancl, M.E., Hu, G., Sangster-Guity, N., Olshalsky, S.L., Hoops, K., Fitzgeraid-Bocarsly, P., Pitha, P.M., Pinder, K., and Barnes, B.J. (2005). Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 280, 21078-21090.
17. Shimane, K., Kochi, Y., Yamada, R., Okada, Y., Suzuki, A., Miyatake, A., Kubo, M., Nakamura, Y., and Yamamoto, K. (2009). A single nucleotide polymorphism in the IRF-5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population. Ann Rheum Dis 68, 377-383.
18. Sigurdsson, S., Göring, H.H., Kristjansdottir, G., Milani, L., Nordmark, G., Sandling, J.K., Eloranta, M.L., Feng, D., Sangster-Guity, N., Gunnarsson, I., Svenungsson, E., Sturfelt, G., Jönsen, A., Truedsson, L., Barnes, B.J., Alm, G., Rönnblom, L., and Syvänen, A.C. (2008). Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF-5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 17, 872-881.
19. Sigurdsson, S., Nordmark, G., Göring, H.H., Lindroos, K., Wiman, A.C., Sturfelt, G., Jönsen, A., Rantapää-Dahlqvist, S., Möller, B., Kere, J., Koskenmies, S., Widen, E., Eloranta, M.L., Julkunen, H., Kristjansdottir, H., Steinsson, K., Alm, G., Rönnblom, L., and Syvänen, A.C. (2005). Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76, 528-537.
20. Soylu, O., Yildirim, A., Coker, A., Tezel, T., List, E.O., and Arman, A. (2008). Interleukin-1B (-511) gene polymorphism is associated with acute coronary syndrome in the Turkish population. Eur Cytokine Netw 19, 42-48.
21. Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S., Honda, K., Ohba, Y., Mak, T.W., and Taniguchi, T. (2005). Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243-249.
22. Yano, K., Reed, D.M., and McGee, D.L. (1984). Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemiol 119, 653-666. (Pubitemid 14142804)